ÌÒÖ­Ó°Ôº

Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY

v3.21.2
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Beginning balance at Apr. 30, 2019 $ 26,461,428 $ 18,666 $ 68,562,727 $ (70,000) $ (42,049,965)
Beginning balance (in shares) at Apr. 30, 2019 Ìý 18,665,551 Ìý Ìý Ìý
Stock-based compensation 2,116,309 Ìý 2,116,309 Ìý Ìý
Amortization of restricted stock issued for services 122,250 Ìý 122,250 Ìý Ìý
Common stock issued for cashless exercise of stock options 0 $ 191 (191) Ìý Ìý
Common stock issued for cashless exercise of stock options (in shares) Ìý 190,559 Ìý Ìý Ìý
Common stock issued for stock options exercised for cash $ 962,650 $ 278 962,372 Ìý Ìý
Common stock issued for stock options exercised for cash (in shares) 363,334 277,678 Ìý Ìý Ìý
Common stock issued for cashless warrant exercise $ 0 $ 77 (77) Ìý Ìý
Common stock issued for cashless warrant exercise (in shares) 76,929 76,929 Ìý Ìý Ìý
Amortization of warrant based cost issued for services $ 36,719 Ìý 36,719 Ìý Ìý
Restricted stock issued for services, subject to vesting 0 $ 144 (144) Ìý Ìý
Restricted stock issued for services, subject to vesting (in shares) Ìý 144,803 Ìý Ìý Ìý
Common stock issued for equity raise, net of underwriter costs of $1,222,371 16,044,879 $ 2,415 16,042,464 Ìý Ìý
Common stock issued in equity raise, net of underwriter costs of $1,222,371 (in shares) Ìý 2,415,000 Ìý Ìý Ìý
Other offering costs (51,282) Ìý (51,282) Ìý Ìý
Beneficial conversion feature on Convertible Debt 1,692,309 Ìý 1,692,309 Ìý Ìý
Common stock short swing reclamation 21,760 Ìý 21,760 Ìý Ìý
Net loss (5,659,065) Ìý Ìý Ìý (5,659,065)
Common stock issued for vested restricted stock units (in shares) Ìý 0 Ìý Ìý Ìý
Ending balance at Apr. 30, 2020 41,747,957 $ 21,771 89,505,216 (70,000) (47,709,030)
Ending balance (in shares) at Apr. 30, 2020 Ìý 21,770,520 Ìý Ìý Ìý
Stock-based compensation 3,958,085 Ìý 3,958,085 Ìý Ìý
Common stock issued for cashless exercise of stock options 0 $ 35 (35) Ìý Ìý
Common stock issued for cashless exercise of stock options (in shares) Ìý 34,773 Ìý Ìý Ìý
Common stock issued for stock options exercised for cash $ 2,669,247 $ 1,389 4,485,272 (1,817,414) Ìý
Common stock issued for stock options exercised for cash (in shares) 52,778 1,389,463 Ìý Ìý Ìý
Amortization of warrant based cost issued for services $ 36,500 Ìý 36,500 Ìý Ìý
Net loss (10,448,973) Ìý Ìý Ìý (10,448,973)
Common stock issued for conversion of Convertible Notes 10,000,000 $ 1,399 9,998,601 Ìý Ìý
Common stock issued for conversion of Convertible Notes (in shares) Ìý 1,398,602 Ìý Ìý Ìý
Common stock issued for vested restricted stock units 0 $ 296 (296) Ìý Ìý
Common stock issued for vested restricted stock units (in shares) Ìý 295,557 Ìý Ìý Ìý
Common stock issued for warrants exercised for cash 1,081,792 $ 192 1,081,600 Ìý Ìý
Common stock issued for warrants exercised for cash (in shares) Ìý 192,049 Ìý Ìý Ìý
Common stock issued for services 19,900 $ 2 19,898 Ìý Ìý
Common stock issued for services (in shares) Ìý 2,000 Ìý Ìý Ìý
Modification charge for warrants exercised 25,966 Ìý 25,966 Ìý Ìý
Cancellation of treasury stock 0 $ (17) (69,983) 70,000 Ìý
Cancellation of treasury stock (in shares) Ìý (16,667) Ìý Ìý Ìý
Ending balance at Apr. 30, 2021 $ 49,090,474 $ 25,067 $ 109,040,824 $ (1,817,414) $ (58,158,003)
Ending balance (in shares) at Apr. 30, 2021 Ìý 25,066,297 Ìý Ìý Ìý